Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery

NCT05943119 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT05943119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05943119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery
Lead sponsor
Centre Francois Baclesse
Phase
Phase 2
Overall status
Recruiting
Start date
March 11, 2024
Completion date
March 31, 2029
Enrollment
52 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

tumor, solid